GlassScriptPhysician profile
Pete P Fong
NPI 1912060906
$8,749.62
in general payments reported to CMS, 2019-2025
12 companies · $4,948 in 2025
The $4,948 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $121 · 2021: $17.92 · 2022: $307 · 2023: $2,527 · 2024: $829 · 2025: $4,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,831 · Travel and Lodging: $3,473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,831.21 |
| Travel and Lodging | $3,473.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,645.29 | 2023-2025 | Symplicity G3, Onyx Frontier, Ffrangio |
| Boston Scientific Corporation | $1,730.36 | 2020-2025 | General - Vascular Intervention, Avvigo Guidance System, Ekosonic |
| Thrombolex, INC. | $766.32 | 2025 | Bashir Endovascular Catheter |
| Abiomed | $472.48 | 2021-2023 | Impella |
| Inari Medical, INC. | $422.42 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $278.57 | 2025 | Indigo System |
| Angiodynamics, INC. | $221.48 | 2024-2025 | Angiovac, Alphavac |
| Abbott Laboratories | $184.72 | 2023-2025 | Hi-Torque Balance, Navitor |
| Zoll Circulation INC | $27.98 | 2022 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pete Fong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.